AI Assistant
Blog
Pricing
Log In
Sign Up
Rivaroxaban attenuates vascular remodeling of heart and lung in PAH through suppression of ERK1/2 and NF-kB phosphorylation
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
